Keyphrases
Genotype-phenotype Analysis
100%
Therapeutic Development
100%
Parkinson's Disease
100%
Alpha-synuclein (α-syn)
87%
Idiopathic Parkinson's Disease
75%
GBA1
37%
Glucocerebrosidase
37%
Disease Genes
25%
DJ-1
25%
ATP13A2
25%
Dopaminergic Neurons
25%
Parkinson's Disease Genetics
12%
PINK1-Parkin Pathway
12%
Lysosomal Enzymes
12%
Parkinsonian Symptoms
12%
VPS35
12%
Parkin
12%
Disease Pathogenesis
12%
Lab Study
12%
Genetic Studies
12%
Neuroprotection
12%
Leucine-rich Repeat Kinase 2 (LRRK2)
12%
Parkinson Patients
12%
New Drug Targets
12%
Lewy Bodies
12%
Mitochondrial Pathway
12%
Family Forms
12%
Neurodegenerative Diseases
12%
Postural Instability
12%
Induced Pluripotent Stem Cells (iPSCs)
12%
Bradykinesia
12%
Lysosomal Disease
12%
Cellular Mechanisms
12%
Muscle Rigidity
12%
Genetic Constructs
12%
Sporadic Form
12%
Endolysosomal System
12%
Family History
12%
Rest Tremor
12%
Biochemistry, Genetics and Molecular Biology
Genotyping
100%
Synuclein
100%
Glucocerebrosidase
42%
Glucosylceramidase
42%
ATP13A2
28%
Dopaminergic
28%
Wild Type
14%
Induced Pluripotent Stem Cell
14%
Genetic Disorder
14%
Enzyme
14%
VPS35
14%
Genetics
14%
PINK1
14%
LRRK2
14%
Rigidity
14%
Neuroscience
Parkinson's Disease
100%
Synuclein
63%
Glucosylceramidase
27%
Dopaminergic Neuron
18%
Parkin
18%
Neuroprotection
9%
Neurodegenerative Disorder
9%
Tremor
9%
Familial Parkinson's Disease
9%
Stem Cell
9%
Bradykinesia
9%
Lysosome Enzyme
9%
Lewy Body
9%